We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PCB:NASDAQPCB Bancorp Analysis

Data as of 2026-04-23 - not real-time

$23.87

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: PCB is trading at $23.87, comfortably above its 20‑day (23.54), 50‑day (22.80) and 200‑day (21.96) simple moving averages, indicating a bullish trend. The RSI sits at 57, showing neutral‑to‑slightly bullish momentum, while the MACD histogram has turned marginally negative, hinting at a short‑term pause. Volume is increasing, support sits around $21.82 and resistance near $24.99, and the stock’s 30‑day volatility is a brisk 21% with a beta under 0.9, suggesting lower market‑wide risk. The market sentiment is extremely greedy (Fear‑Greed Index 86.95), which may be pricing in optimism.
Fundamental outlook: Valuation appears attractive – a trailing P/E of 9.3 versus the industry average of 17.5, and a price‑to‑book of just 1.05. Revenue is growing 16% YoY, operating margins are robust at 46.7%, and net profit margin is 33.5%. The balance sheet is strong with $207 M cash against $53 M debt, and the dividend yield of 3.42% is supported by a modest 31% payout ratio. Forward earnings imply an even lower forward P/E of 7.8, underscoring potential upside.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price is near short‑term resistance around $24.99
  • MACD histogram has turned slightly negative
  • Strong dividend yield of 3.42% provides downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Revenue growth of 16% YoY and operating margin above 45%
  • Valuation discount to peers (P/E 9.3 vs industry 17.5)
  • Solid cash position and low debt enhances financial stability

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair‑value estimate suggests significant upside
  • Low beta and consistent dividend support defensive profile
  • Sustained profitability and capital strength for future growth

Key Metrics & Analysis

Financial Health

Revenue Growth16.30%
Profit Margin33.53%
P/E Ratio9.3
ROE9.94%
ROA1.18%
P/B Ratio1.1
Op. Cash Flow$26.6M
Industry P/E17.5

Technical Analysis

TrendBullish
RSI57.3
Support$21.82
Resistance$24.99
MA 20$23.54
MA 50$22.80
MA 200$21.96
MACDBearish
VolumeIncreasing
Fear & Greed Index86.95

Valuation

Fair Value$45.63
Target Price$25.25
Upside/Downside5.78%
GradeUndervalued
TypeBlend
Dividend Yield3.42%

Risk Assessment

Beta0.82
Volatility21.25%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.